Five groups it does not suit
One decided by the ingredient list, and four decided by federal pages that cover single rows on this panel.
Five groups, in the order the consequences matter. The first is decided by the
ingredient list; the next four by federal safety pages covering individual rows on this
panel.
Vegetarians and vegans
This is the clearest exclusion on the product and it is decided by the label. The other-ingredients line reads “Rice Flour, Gelatin, Magnesium Stearate…” Gelatin is boiled-down animal collagen. The vegetarian mark in the marketing pack does not change what is in the capsule.
There is no caveat to add and no second reading available. If you keep a vegetarian or
vegan diet, stop here; nothing further down this page can change the answer.
Anyone taking a blood thinner or an antiplatelet
Three rows — vitamin E, ginkgo and Asian ginseng — carry published anticoagulant cautions, and they are in the same capsule twice a day. ODS on vitamin E: it “can increase the risk of bleeding in people taking anticoagulant or antiplatelet medicines, such as warfarin”. This is a pharmacist question, not a comment-section question.
Read the stack rather than the rows. Three of the fourteen rows carry the same published warning, and they are in the same capsule. Vitamin E, per NIH ODS, “can increase the risk of bleeding in people taking anticoagulant or antiplatelet medicines, such as warfarin (Coumadin)”. Ginkgo, per NCCIH, “may increase the risk of bleeding in people who are taking anticoagulant drugs, such as warfarin”. Asian ginseng, per NCCIH, “may worsen autoimmune disorders and interfere with blood clotting”. None of those three amounts is extreme on its own. The point is that they arrive together, in one bottle, taken twice a day, by an age group that is more likely than most to be on a blood thinner already.
Read a multi-botanical panel for repeats, not just for totals. When three separate rows carry the same caution, the caution is the formula’s, not the ingredient’s. The label’s own line — consult a physician if you take any medication — is the right instruction, and this is the formula that earns it.
Anyone who flushes, or who is already taking niacin
75 mg is more than twice the 35 mg supplemental upper limit, and ODS reports that 30 mg or more of nicotinic acid can turn the skin of the face, arms and chest red, burning and itchy. The label does not say which form of niacin it uses.
What the panel cannot tell you is which form of niacin it is, because it does not say.
Nicotinic acid flushes from about 30 mg upwards; niacinamide does not. On a
75 mg row that one missing word decides how the capsule will feel.
Anyone buying it for urinary symptoms
Saw palmetto is the ingredient people buy for that, and NCCIH’s 2023 review of 27 studies found it “provides little or no benefit for BPH symptoms”. This bottle has 84.5 mg of unstandardised fruit against the roughly 320 mg of standardised extract the trials used. MedlinePlus is plain that these symptoms “could be from a more serious health problem”.
This is the exclusion most likely to be argued with, so here is the evidence in full.
NCCIH: “A 2023 review of 27 studies on saw palmetto in men with BPH found that this herb, when administered alone, provides little or no benefit for BPH symptoms.” And of two further trials:
“In both studies, saw palmetto did not improve BPH symptoms.” Even if those reviews had come back positive,
84.5 mg of unstandardised fruit is roughly a quarter of the studied amount, in a
different preparation. MedlinePlus is plain about why that matters here: on the symptoms
of an enlarged prostate, “It’s important to see your health care provider if you have any of these symptoms because they could be from a more serious health problem.”
Anyone with an autoimmune condition, or on a diabetes medicine
NCCIH: Asian ginseng “may worsen autoimmune disorders” and “might lower blood sugar levels”. Both are conversations to have before the first capsule rather than after.
Both come from the same NCCIH page, and both attach to the one ingredient on this
panel with a positive finding behind it: the row most likely to do something useful is
also the row carrying the most conditions on who should take it.